{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T08:50:14Z","timestamp":1745052614066},"reference-count":26,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.3892\/or.2017.5688","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T08:57:43Z","timestamp":1496307463000},"page":"481-487","source":"Crossref","is-referenced-by-count":4,"title":["KML001 and doxercalciferol induce synergistic antileukemic effect in acute lymphoid leukemia cells"],"prefix":"10.3892","volume":"38","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Yeop","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somi","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youngil","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"key":"key20180107220844_b1-or-38-01-0481","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdllow","year":"2008","edition":"4th"},{"key":"key20180107220844_b2-or-38-01-0481","doi-asserted-by":"crossref","first-page":"59","DOI":"10.12703\/P6-59","article-title":"Pathogenesis and prognostication in acute lymphoblastic leukemia","volume":"6","author":"Zuckerman","year":"2014","journal-title":"F1000Prime Rep"},{"key":"key20180107220844_b3-or-38-01-0481","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/asheducation.V2012.1.129.3800156","article-title":"Where do we stand in the treatment of relapsed acute lymphoblastic leukemia? Hematology","volume":"2012","author":"Raetz","year":"2012","journal-title":"Am Soc Hematol Educ Program"},{"key":"key20180107220844_b4-or-38-01-0481","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1517\/14656566.9.10.1773","article-title":"Arsenic trioxide","volume":"9","author":"Litzow","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"key20180107220844_b5-or-38-01-0481","doi-asserted-by":"crossref","first-page":"e0137589","DOI":"10.1371\/journal.pone.0137589","article-title":"KML001 induces apoptosis and autophagic cell death in prostate cancer cells via oxidative stress pathway","volume":"10","author":"You","year":"2015","journal-title":"PLoS One"},{"key":"key20180107220844_b6-or-38-01-0481","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3892\/ijo.2015.2899","article-title":"Anti-leukemic effect of sodium metaarsenite (KML001) in acute myeloid leukemia with breaking-down the resistance of cytosine arabinoside","volume":"46","author":"Yoon","year":"2015","journal-title":"Int J Oncol"},{"key":"key20180107220844_b7-or-38-01-0481","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/toxsci\/kfu029","article-title":"Cisplatin plus sodium arsenite and hyperthermia induces pseudo-G1 associated apoptotic cell death in ovarian cancer cells","volume":"139","author":"Muenyi","year":"2014","journal-title":"Toxicol Sci"},{"key":"key20180107220844_b8-or-38-01-0481","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10637-015-0301-z","article-title":"Anti-tumoral effect of arsenic compound, sodium metaarsenite (KML001), in non-Hodgkin's lymphoma: An in vitro and in vivo study","volume":"34","author":"Yoon","year":"2016","journal-title":"Invest New Drugs"},{"key":"key20180107220844_b9-or-38-01-0481","first-page":"2687","article-title":"The association of solar ultraviolet B (UVB) with reducing risk of cancer: Multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates","volume":"26A","author":"Grant","year":"2006","journal-title":"Anticancer Res"},{"key":"key20180107220844_b10-or-38-01-0481","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/jnci\/djj101","article-title":"Prospective study of predictors of vitamin D status and cancer incidence and mortality in men","volume":"98","author":"Giovannucci","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"key20180107220844_b11-or-38-01-0481","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/endo-108-3-1083","article-title":"1,25-dihydroxyvitamin D3 and malignant melanoma: The presence of receptors and inhibition of cell growth in culture","volume":"108","author":"Colston","year":"1981","journal-title":"Endocrinology"},{"key":"key20180107220844_b12-or-38-01-0481","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0006-291X(81)91628-4","article-title":"1\u03b1,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells","volume":"102","author":"Miyaura","year":"1981","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107220844_b13-or-38-01-0481","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/(SICI)1097-4644(19961215)63:4<500::AID-JCB11>3.0.CO;2-H","article-title":"Vitamin D analog 25-(OH)-16,23E-Diene-26,27-hexafluoro-vitamin D3 induces differentiation of HL60 cells with minimal effects on cellular calcium homeostasis","volume":"63","author":"Gardner","year":"1996","journal-title":"J Cell Biochem"},{"key":"key20180107220844_b14-or-38-01-0481","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0145-2126(83)90057-7","article-title":"1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells","volume":"7","author":"McCarthy","year":"1983","journal-title":"Leuk Res"},{"key":"key20180107220844_b15-or-38-01-0481","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4161\/cc.5.4.2467","article-title":"AKT pathway is activated by 1, 25-dihydroxyvitamin D3 and participates in its anti-apoptotic effect and cell cycle control in differentiating HL60 cells","volume":"5","author":"Zhang","year":"2006","journal-title":"Cell Cycle"},{"key":"key20180107220844_b16-or-38-01-0481","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jsbmb.2004.03.010","article-title":"Calcium as a mediator of 1,25-dihydroxyvitamin D3-induced apoptosis","author":"Sergeev","year":"2004","journal-title":"J Steroid Biochem Mol Biol 89\u201390"},{"key":"key20180107220844_b17-or-38-01-0481","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/10428190701713648","article-title":"Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome","volume":"49","author":"Petrich","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"key20180107220844_b18-or-38-01-0481","first-page":"4077","article-title":"Phase II study of 1\u03b1-hydroxyvitamin D(2) in the treatment of advanced androgen-independent prostate cancer","volume":"9","author":"Liu","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key20180107220844_b19-or-38-01-0481","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"key20180107220844_b20-or-38-01-0481","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1038\/sj.onc.1207528","article-title":"Cell death by mitotic catastrophe: A molecular definition","volume":"23","author":"Castedo","year":"2004","journal-title":"Oncogene"},{"key":"key20180107220844_b21-or-38-01-0481","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1038\/sj.onc.1207572","article-title":"Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy","volume":"23","author":"Castedo","year":"2004","journal-title":"Oncogene"},{"key":"key20180107220844_b22-or-38-01-0481","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"p21 in cancer: Intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key20180107220844_b23-or-38-01-0481","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/sj.onc.1204252","article-title":"Regulation of the G2\/M transition by p53","volume":"20","author":"Taylor","year":"2001","journal-title":"Oncogene"},{"key":"key20180107220844_b24-or-38-01-0481","doi-asserted-by":"crossref","first-page":"747415","DOI":"10.1155\/2014\/747415","article-title":"KML001, a telomere-targeting drug, sensitizes glioblastoma cells to temozolomide chemotherapy and radiotherapy through DNA damage and apoptosis","volume":"2014","author":"Woo","year":"2014","journal-title":"BioMed Res Int"},{"key":"key20180107220844_b25-or-38-01-0481","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1101\/gad.13.15.1899","article-title":"BCL-2 family members and the mitochondria in apoptosis","volume":"13","author":"Gross","year":"1999","journal-title":"Genes Dev"},{"key":"key20180107220844_b26-or-38-01-0481","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.pharmtox.41.1.421","article-title":"Cancer chemoprevention using natural vitamin D and synthetic analogs","volume":"41","author":"Guyton","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T05:01:16Z","timestamp":1602219676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2017.5688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,6,1]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.3892\/or.2017.5688"],"URL":"https:\/\/doi.org\/10.3892\/or.2017.5688","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}